Efficacy and safety of sintilimab in combination with XELOX in first-line gastric or gastroesophageal junction carcinoma (GC/GEJC).

被引：3
|
作者：
Xu, Nong
Shen, Lin
Jiang, Haiping
Zheng, Yulong
Qian, Jiong
Mao, Chenyu
Zhou, Hui
Wang, Shuyan
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
[2] Beijing Canc Hosp, Beijing, Peoples R China
[3] Innovent Biol Suzhou Co Ltd, Suzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.4042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4042
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of sintilimab in combination with XELOX in first-line gastric or Gastroesophageal Junction Carcinoma (GC/GEJC)
    Teng, L.
    Xu, N.
    Jiang, H.
    Zheng, Y.
    Qian, J.
    Mao, C.
    Zhou, H.
    Wang, S.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1759 - 1760
  • [2] A phase Ib/II study of fruquintinib in combination with SOX and toripalimab as first-line treatment for advanced metastatic gastric/gastroesophageal junction adenocarcinoma (GC/GEJC).
    Meng, Xiangrui
    Shan, Zhengzheng
    Guan, Lulu
    Dao, Xin
    Fan, Qingxia
    Wang, Feng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 335 - 335
  • [3] First-line immunochemotherapy modulates peripheral immune landscape in advanced gastric cancer and gastroesophageal junction cancer (GC/GEJC): Prediction of response to combination therapy
    Wu, Hao
    Meng, Enqing
    Li, Ping
    Jiang, Rongqi
    Cheng, Xu
    Zhu, Chan
    Zhang, Xing
    Chen, Dongsheng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] THE GLOBAL BURDEN OF GASTRIC (GC) AND GASTROESOPHAGEAL JUNCTION (GEJC) CANCERS
    Morlock, R.
    Duran, A.
    Holmstrom, S.
    Casamayor, M.
    Gani, R.
    Pandya, B. J.
    van Engen, A.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A460 - A460
  • [5] Safety and efficacy of tislelizumab plus chemotherapy for first-line treatment of advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma
    Qiu, Hai-Bo
    [J]. THORACIC CANCER, 2020, 11 (12) : 3419 - 3421
  • [6] Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial
    Haiping Jiang
    Yulong Zheng
    Jiong Qian
    Chenyu Mao
    Xin Xu
    Ning Li
    Cheng Xiao
    Huan Wang
    Lisong Teng
    Hui Zhou
    Shuyan Wang
    Donglei Zhu
    Bo Peng
    Lin Shen
    Nong Xu
    [J]. BMC Cancer, 20
  • [7] Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial
    Jiang, Haiping
    Zheng, Yulong
    Qian, Jiong
    Mao, Chenyu
    Xu, Xin
    Li, Ning
    Xiao, Cheng
    Wang, Huan
    Teng, Lisong
    Zhou, Hui
    Wang, Shuyan
    Zhu, Donglei
    Peng, Bo
    Shen, Lin
    Xu, Nong
    [J]. BMC CANCER, 2020, 20 (01)
  • [8] Efficacy and safety of IBI110 in combination with sintilimab in first-line advanced HER2negative gastric cancer or gastroesophageal junction cancer: Updated results from a phase Ib study
    Mao, Chenyu
    Qian, Jiong
    Gao, Yuan
    Liu, Ying
    Zhang, Tao
    Cui, Jiuwei
    Chen, Yuling
    Chen, Haonan
    Zhao, Li
    Wang, Hongli
    Xu, Nong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Tislelizumab in combination with chemotherapy for Chinese patients (Pts) with gastric/gastroesophageal junction cancer (GC/GEJC) or esophageal squamous cell carcinoma (ESCC)
    Bai, Y.
    Xu, N.
    Yuan, X.
    Wang, B.
    Li, E.
    Li, X.
    Li, Y.
    Wang, X.
    Yang, S.
    Xu, J.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [10] Efficacy and safety of IBI110 in combination with sintilimab in first-line advanced HER2-negative gastric cancer or gastroesophageal junction cancer: Preliminary results from a phase Ib study.
    Mao, Chenyu
    Qian, Jiong
    Gao, Yuan
    Liu, Ying
    Zhang, Tao
    Cui, Jiuwei
    Liu, Ying
    Chen, Yiwei
    Zhao, Li
    Xu, Nong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16097 - E16097
12345